These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35393874)

  • 1. Design of the DAVOS Study: Diabetes Smartphone App, a Fully Automatic Transmission of Data From the Blood Glucose Meter and Insulin Pens Using Wireless Technology to Enhance Diabetes Self-Management-A Study Protocol for a Randomized Controlled Trial.
    Grosser F; Herrmann S; Bretschneider M; Timpel P; Schildt J; Bentrup M; Schwarz PEH
    J Diabetes Sci Technol; 2023 May; 17(3):742-750. PubMed ID: 35393874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of diabetes self-management education via a smartphone application in insulin treated type 2 diabetes patients - design of a randomised controlled trial ('TRIGGER study').
    Boels AM; Rutten G; Zuithoff N; de Wit A; Vos R
    BMC Endocr Disord; 2018 Oct; 18(1):74. PubMed ID: 30348142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health care effects and medical benefits of a smartphone-based diabetes self-management application: study protocol for a randomized controlled trial.
    Ehrmann D; Eichinger V; Vesper I; Kober J; Kraus M; Schäfer V; Hermanns N; Kulzer B; Silbermann S
    Trials; 2022 Apr; 23(1):282. PubMed ID: 35410241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mobile App for Improved Self-Management of Type 2 Diabetes: Multicenter Pragmatic Randomized Controlled Trial.
    Agarwal P; Mukerji G; Desveaux L; Ivers NM; Bhattacharyya O; Hensel JM; Shaw J; Bouck Z; Jamieson T; Onabajo N; Cooper M; Marani H; Jeffs L; Bhatia RS
    JMIR Mhealth Uhealth; 2019 Jan; 7(1):e10321. PubMed ID: 30632972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a Digital Health Tool for Titration of Basal Insulin in People With Type 2 Diabetes: Rationale and Design of a Randomized Controlled Trial.
    Hermanns N; Ehrmann D; Finke-Gröne K; Roos T; Freckmann G; Kulzer B
    J Diabetes Sci Technol; 2024 Jul; 18(4):946-955. PubMed ID: 36602040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An automated structured education intervention based on a smartphone app in Chinese patients with type 1 diabetes: a protocol for a single-blinded randomized controlled trial.
    Huang F; Wu X; Xie Y; Liu F; Li J; Li X; Zhou Z
    Trials; 2020 Nov; 21(1):944. PubMed ID: 33225982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Save Medical Corporation (SMC)-01, a Smartphone App Designed to Support Type 2 Diabetes Self-Management Based on Established Guidelines: Randomized Controlled Trial.
    Leung N; Waki K; Nozoe S; Enomoto S; Saito R; Hamagami S; Yamauchi T; Nangaku M; Ohe K; Onishi Y
    J Med Internet Res; 2024 Sep; 26():e53740. PubMed ID: 39255478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of Smartphone App-Based Interactive Management on Glycemic Control in Chinese Patients With Poorly Controlled Diabetes: Randomized Controlled Trial.
    Zhang L; He X; Shen Y; Yu H; Pan J; Zhu W; Zhou J; Bao Y
    J Med Internet Res; 2019 Dec; 21(12):e15401. PubMed ID: 31815677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a smartphone application for helping individuals with type 2 diabetes mellitus manage their blood glucose: a protocol for factorial design trial.
    Tang H; Qin H; Zhang M; Zhang J; Tan H; Chen M; Kong L; Guo M; Hu F; Wang Q; Wang X; Zhang K; Xiong Z
    Trials; 2023 Jul; 24(1):468. PubMed ID: 37480092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a smartphone application (KAIA COPD app) in combination with Activity Monitoring as a maintenance prOgram following PUlmonary Rehabilitation in COPD: the protocol for the AMOPUR Study, an international, multicenter, parallel group, randomized, controlled study.
    Spielmanns M; Boeselt T; Huber S; Kaur Bollinger P; Ulm B; Peckaka-Egli AM; Jarosch I; Schneeberger T; Schoendorf S; Gloeckl R; Koczulla AR
    Trials; 2020 Jul; 21(1):636. PubMed ID: 32653025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Makes FLASH the difference between the intervention group and the treatment-as-usual group in an evaluation study of a structured education and treatment programme for flash glucose monitoring devices in people with diabetes on intensive insulin therapy: study protocol for a randomised controlled trial.
    Schipfer M; Albrecht C; Ehrmann D; Haak T; Kulzer B; Hermanns N
    Trials; 2018 Feb; 19(1):91. PubMed ID: 29402319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an information system and mobile application for the care of type 2 diabetes patients at the primary care level for the health sector in Mexico: study protocol for a randomized controlled, open-label trial.
    Barengo NC; Apolinar LM; Estrada Cruz NA; Fernández Garate JE; Correa González RA; Diaz Valencia PA; Gonzalez CAC; Rodriguez JAG; González NC;
    Trials; 2022 Apr; 23(1):253. PubMed ID: 35379298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. App to support Recovery in Early Intervention Services (ARIES) study: protocol of a feasibility randomised controlled trial of a self-management Smartphone application for psychosis.
    Steare T; O'Hanlon P; Eskinazi M; Osborn D; Lloyd-Evans B; Jones R; Rostill H; Amani S; Johnson S
    BMJ Open; 2019 Mar; 9(3):e025823. PubMed ID: 30898825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Users' acceptability of a mobile application for persons with type 2 diabetes: a qualitative study.
    Torbjørnsen A; Ribu L; Rønnevig M; Grøttland A; Helseth S
    BMC Health Serv Res; 2019 Sep; 19(1):641. PubMed ID: 31492176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Personalized Diabetes Self-care Using an Electronic Medical Record-Integrated Mobile App in Patients With Type 2 Diabetes: 6-Month Randomized Controlled Trial.
    Lee EY; Cha SA; Yun JS; Lim SY; Lee JH; Ahn YB; Yoon KH; Hyun MK; Ko SH
    J Med Internet Res; 2022 Jul; 24(7):e37430. PubMed ID: 35900817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An information and communication technology-based centralized clinical trial to determine the efficacy and safety of insulin dose adjustment education based on a smartphone personal health record application: a randomized controlled trial.
    Kim G; Bae JC; Yi BK; Hur KY; Chang DK; Lee MK; Kim JH; Jin SM
    BMC Med Inform Decis Mak; 2017 Jul; 17(1):109. PubMed ID: 28720103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving Diabetes Equity and Advancing Care (IDEA) to optimize team-based care at a safety-net health system for Black and Latine patients living with diabetes: study protocol for a sequential, multiple assignment, randomized trial.
    Jacobs J; Labellarte P; Margellos-Anast H; Garcia L; Qeadan F; Tingey B; Barnick K; Dougherty A; Wagener C
    Trials; 2024 Jul; 25(1):504. PubMed ID: 39049044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A group- and smartphone-based psychological intervention to increase and maintain physical activity in patients with musculoskeletal conditions: study protocol for a randomized controlled trial ("MoVo-App").
    Lin J; Wurst R; Paganini S; Hohberg V; Kinkel S; Göhner W; Ramsenthaler C; Fuchs R
    Trials; 2020 Jun; 21(1):502. PubMed ID: 32513291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mobile app using therapeutic exercise and education for self-management in patients with hand rheumatoid arthritis: a randomized controlled trial protocol.
    Rodríguez-Sánchez-Laulhé P; Luque-Romero LG; Blanquero J; Suero-Pineda A; Biscarri-Carbonero Á; Barrero-García FJ; Heredia-Rizo AM
    Trials; 2020 Sep; 21(1):777. PubMed ID: 32912305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.